OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Canalization and plasticity in psychopathology
Robin Carhart‐Harris, Shamil Chandaria, David Erritzøe, et al.
Neuropharmacology (2022) Vol. 226, pp. 109398-109398
Open Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

A Unified Pathogenic Hypothesis for Mental Disorders Based on Schismogenesis
Mauro García‐Toro, Rocío Gómez-Juanes
Biosystems (2025), pp. 105431-105431
Closed Access

Psilocybin and Other Classic Psychedelics in Depression
David Nutt, Joseph Peill, Brandon Weiss, et al.
Current topics in behavioral neurosciences (2023), pp. 149-174
Closed Access | Times Cited: 9

From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder
Jeremy Weleff, Julio C. Nunes, Gabriel P. A. Costa, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 3

When the interoceptive and conceptual clash: The case of oppositional phenomenal self-modelling in Tourette syndrome
Darius Parvizi-Wayne, Liberty Severs
Cognitive Affective & Behavioral Neuroscience (2024) Vol. 24, Iss. 4, pp. 660-680
Open Access | Times Cited: 3

Psychotomimetic compensation versus sensitization
Ari Brouwer, Robin Carhart‐Harris, Charles L. Raison
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3

Ligands of the trace amine-associated receptors (TAARs): A new class of anxiolytics
Yazen Alnefeesi, Ilya Sukhanov, Raul R. Gainetdinov
Pharmacology Biochemistry and Behavior (2024) Vol. 242, pp. 173817-173817
Closed Access | Times Cited: 3

Human brain changes after first psilocybin use
Terence J. Lyons, Merle Spriggs, Leevi Kerkelä, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Leveraging meditation research for the study of psychedelic-related adverse effects
Roman Palitsky, Nicholas K. Canby, Nicholas T. Van Dam, et al.
International Review of Psychiatry (2024), pp. 1-15
Closed Access | Times Cited: 3

Focusing on the negative: cases of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
(2023)
Open Access | Times Cited: 8

Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey
E. Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, et al.
Alcohol and Alcoholism (2023) Vol. 59, Iss. 2
Closed Access | Times Cited: 7

A dual-receptor model of serotonergic psychedelics
Arthur Juliani, Veronica Chelu, Laura Graesser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies
Maya Armstrong, Joel Castellanos, Devon Christie
Frontiers in Pain Research (2024) Vol. 5
Open Access | Times Cited: 1

Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks
Evan Lewis, Alexandria Jaeger, Manesh Girn, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 407-416
Open Access | Times Cited: 1

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
Julia Bornemann, James B. Close, Kirran Ahmad, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1

Decoupling of cortical activity from behavioral state following administration of the classic psychedelic DOI
Randall J. Olson, Lowell Bartlett, Alex Sonneborn, et al.
Neuropharmacology (2024) Vol. 257, pp. 110030-110030
Closed Access | Times Cited: 1

Towards an End-to-End Personal Fine-Tuning Framework for AI Value Alignment
Eleanor Watson, Thiago Viana, Shujun Zhang, et al.
Electronics (2024) Vol. 13, Iss. 20, pp. 4044-4044
Open Access | Times Cited: 1

Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression
Matthew B. Wall, Lysia Demetriou, Bruna Giribaldi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

Scroll to top